Antiviral therapy decreases recurrence of hepatitis b virus-related hepatocellular carcinoma after curative resection: A meta-analysis

World Journal of Surgery

Volumn 38, Issue 9, 2014, Pages 2395-2402

  Zhou, Yanming ^a   Zhang, Zhansai ^b   Zhao, Yanfang ^c   Wu, Lupeng ^a   Li, Bin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b Shanghai Institute of Occupational Safety and Health   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA;

AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; MALE; META ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTOR; VIROLOGY; VIRUS LOAD;

AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HEPATECTOMY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; VIRAL LOAD;

EID: 84905716077     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2586-z     Document Type: Article

References (46)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576
2. Papatheodoridis GV, Lampertico P, Manolakopoulos S et al (2010) Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 53:348-356
3. Zhou Y, Sui C, Li B et al (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8:55
4. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232:10-24
5. Hung IF, Poon RT, Lai CL et al (2008) Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol 103:1663-1673
6. Kim BK, Park JY, Kim do Y et al (2008) Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int 28:393-401
7. Kubo S, Tanaka H, Takemura S et al (2007) Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol Res 37:94-100
8. Piao CY, Fujioka S, Iwasaki Y et al (2005) Lamivudine treatment in patients with HBV-related hepatocellular carcinoma - using an untreated, matched control cohort. Acta Med Okayama 59:217-224
9. Kuzuya T, Katano Y, Kumada T et al (2007) Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol Hepatol 22:1929-1935
10. Chuma M, Hige S, Kamiyama T et al (2009) The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol 44:991-999
11. Koda M, Nagahara T, Matono T et al (2009) Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function. Intern Med 48:11-17
12. Li N, Lai EC, Shi J et al (2010) A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Ann Surg Oncol 17:179-185
13. Chan AC, Chok KS, Yuen WK et al (2011) Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg 146:675-681
14. Jadad AR, Moore RA, Carroll D et al (1996) Assessment the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
15. Simillis C, Constantinides VA, Tekkis PP et al (2007) Laparoscopic versus open hepatic resections for benign and malignant neoplasms - a meta-analysis. Surgery 141:203-211
16. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834
17. Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16
18. Cai X, Huang C, Zhou H et al (2008) Postoperative serum HBV DNA level evaluate the recurrence after radical resection for patients with HBV-related hepatocellular carcinoma [in Chinese]. J Fujian Med Univ 42:438-440
19. Wu JC, Huang YH, Chau GY et al (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51:890-897
20. An HJ, Jang JW, Bae SH et al (2010) Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 25:1876-1882
21. Qu LS, Jin F, Huang XW et al (2010) High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg 14:1111-1120
22. Yang M, Xiao L, Shi X (2010) A study of antiviral therapy in prevention of tumor recurrence after curative treatment of hepatocellular carcinoma [in Chinese]. Med J Chin PLA 35:726-732
23. Yeh CT, So M, Ng J et al (2010) Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 52:1922-1933
24. Cheng F, Lv L, Sun B et al (2011) A study of antiviral therapy in prevention of tumor recurrence after radical liver resection of hepatocellular carcinoma with high load of hepatitis B virus DNA [in Chinese]. Acta Univ Med Nanjing 31:882-888
25. Choi JG, Chung YH, Kim JA et al (2012) High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection. J Clin Gastroenterol 46:413-419
26. Feng J, Li J, Fang T et al (2012) The effect of adefovir dipivoxil on the prognosis of HBV positive hepatocellular carcinoma [in Chinese]. China Modern Doctor 50:50-54
27. Urata Y, Kubo S, Takemura S et al (2012) Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 19:685-696
28. Wu CY, Chen YJ, Ho HJ et al (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906-1914
29. Yang T, Lu JH, Zhai J et al (2012) High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Eur J Surg Oncol 38:683-691
30. Su CW, Chiou YW, Tsai YH et al (2013) The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy. PLoS One 8:e66457
31. Yin J, Li N, Han Y et al (2013) Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study. J Clin Oncol 31:3647-3655
32. Zhang Z, Geng X, Zhao H et al (2013) The clinical significance of antiviral therapy for hepatocellular carcinoma with positive HBV-DNA patients [in Chinese]. J Hepatobiliary Surg 21:177-180
33. Tsai WL, Chung RT (2010) Viral hepatocarcinogenesis. Oncogene 29:2309-2324
34. Manigold T, Rehermann B (2003) Chronic hepatitis B and hepatocarcinogenesis: does prevention of "collateral damage" bring the cure? Hepatology 37:707-710
35. Chen CJ, Yang HI, Su J et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65-73
36. Mendy ME, Welzel T, Lesi OA et al (2010) Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat 17:115-122
37. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200-207
38. Breitenstein S, Dimitroulis D, Petrowsky H et al (2009) Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg 96:975-981
39. Lin SM, Sheen IS, Chien RN et al (1999) Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 29:971-975
40. Lo CM, Liu CL, Chan SC et al (2007) A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 245:831-842
41. Chen LT, Chen MF, Li LA et al (2012) Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg 255:8-17
42. Wong JS, Wong GL, Tsoi KK et al (2011) Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther 33:1104-1112
43. Qu LS, Liu JX, Kuai XL, et al (2013) Significance of viral status on recurrence of hepatitis B-related hepatocellular carcinoma after curative therapy: a meta-analysis. Hepatol Res. doi: 10.1111/hepr.12172
44. Chung GE, Kim W, Lee JH et al (2011) Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. J Gastroenterol Hepatol 26:1638-1645
45. Zhou Y, Zhao Y, Li B et al (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10:78
46. McKay A, Mackenzie S, Sutherland FR et al (2006) Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93:929-936